mTOR pathway activation in age-related retinal disease

Aging

Volumn 3, Issue 4, 2011, Pages 346-347

  Zhao, Chen ^a,b   Vollrath, Douglas ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b TIANJIN EYE HOSPITAL   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

AGING; ARTICLE; HUMAN; METABOLISM; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIGMENT EPITHELIUM; RETINA DISEASE; RETINA MACULA DEGENERATION; SIGNAL TRANSDUCTION;

AGING; HUMANS; MACULAR DEGENERATION; OXIDATIVE PHOSPHORYLATION; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 80052084689     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100303     Document Type: Note

References (15)

1. Zarbin MA. Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol. 2004;122:598-614.
2. Marmor MF and Wolfensberger WT. 1999. The Retinal Pigment Epithelium Function and Disease (New York: Oxford University Press).
3. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, and Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
4. Cai J, Nelson KC, Wu M, Sternberg P Jr, and Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
5. Jarrett SG, Lin H, Godley BF, and Boulton ME. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res. 2008;27:596-607.
6. Karunadharma PP, Nordgaard CL, Olsen TW, and Ferrington DA. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;51:5470-5479.
7. Lin H, Xu H, Liang FQ, Liang H, Gupta P, Havey AN, Boulton ME, and Godley BF. Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011.
8. Zhao C, Yasumura D, Li X, Matthes M, Lloyd M, Nielsen G, Ahern K, Snyder M, Bok D, Dunaief JL, et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest. 2011;121:369-383.
9. Zoncu R, Efeyan A, and Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12:21-35.
10. Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC, and Thomas G. Mammalian TOR: a homeostatic ATP sensor. Science. 2001;294:1102-1105.
11. Justilien V, Pang JJ, Renganathan K, Zhan X, Crabb JW, Kim SR, Sparrow JR, Hauswirth WW, and Lewin AS. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci. 2007;48:4407-4420.
12. Rattner A, Toulabi L, Williams J, Yu H, and Nathans J. The genomic response of the retinal pigment epithelium to light damage and retinal detachment. J Neurosci. 2008;28:9880-9889.
13. Bruban J, Glotin AL, Dinet V, Chalour N, Sennlaub F, Jonet L, An N, Faussat AM, and Mascarelli F. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell. 2009;8:162-177.
14. Hussain AA, Rowe L, and Marshall J. Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J Opt Soc Am A Opt Image Sci Vis. 2002;19:166-172.
15. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392-395.